BioCentury
ARTICLE | Company News

Management tracks

January 14, 2016 1:30 AM UTC

Rare disease company Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) hired Mary Szela as CEO. Sandford Smith had been interim CEO since Marc Beer's resignation in July 2015. Szela was CEO of Melinta Therapeutics Inc. (New Haven, Conn.).

Cancer company Oncothyreon Inc. (NASDAQ:ONTY) said CEO Robert Kirkman retired. Chairman Christopher Henney will be interim CEO while Oncothyreon searches for a replacement. ...